|

PROMIS Evaluation Study

RECRUITINGSponsored by Bezirkskrankenhaus St. Johann in Tirol
Actively Recruiting
SponsorBezirkskrankenhaus St. Johann in Tirol
Started2023-02-09
Est. completion2026-02-09
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT05734651

Summary

A total of 250 total hip arthroplasties (THA) are performed at the Bezirkskrankenhaus St. Johann. In a majority of those, implants from the company Falcon Medical (Austria) are used. Those implants are undergoing constant development and improvement. To guarantee their clinical performance, this clinical study is evaluating safety and efficacy of all implants produced by Falcon Medical. The purpose of this study is to evaluate the effcacy and safety of implants produced and distributed by Falcon Medical. All patients with primary THA and usage of a Falcon Medical implant are included. The outcome measures include intra-operative complications, early post-operative complications, revision for any cause and patient reported outcome (WOMAC questionnaire). All data is prospectively collected in a standardized fashion.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Primary total hip arthroplasty with the PROMIS stem

Exclusion Criteria:

* n/a

Conditions6

ArthritisFemoral Neck FracturesHip ArthropathyOsteoarthritis, HipOsteonecrosisPerthes Disease

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.